<DOC>
	<DOCNO>NCT02551497</DOCNO>
	<brief_summary>This double-blind , randomise , placebo-controlled 3 period study evaluate interaction drug CNV1014802 healthy male female subject . It plan enrol 36 subject .</brief_summary>
	<brief_title>Study Evaluate Interaction Between Drug CNV1014802 Healthy Subjects</brief_title>
	<detailed_description />
	<criteria>Healthy male , nonpregnant , nonlactating healthy female either nonchild bearing potential , take approve method contraception duration study Age 18 55 year age , inclusive Nonsmoking subject body weight ≥45 kg Body mass index ( BMI ) 18 32 kg/m2 ( inclusive ) Must willing able communicate participate whole study Must provide write informed consent Must agree use adequate method contraception Participation clinical research study within previous 3 month Subjects study site employee , immediate family member study site sponsor employee Subjects previously enrol study History drug alcohol abuse past 2 year History regular alcohol consumption within 6 month study ( male subject &gt; 21 unit per week female subject &gt; 14 unit per week ; 1 unit = ½ pint beer , 25 mL 40 % spirit 125 mL glass wine ) Positive alcohol breath test Current smoker smoke within last 6 month . A breath carbon monoxide read great 10 ppm screen Females childbearing potential pregnant lactating ( female subject must negative urine pregnancy test admission ) Subjects suitable vein multiple venepunctures/cannulation assess investigator screen Clinically significant abnormal biochemistry , haematology urinalysis Positive drug abuse test result Positive hepatitis B surface antigen ( HBsAg ) , hepatitis C virus antibody ( HCV Ab ) human immunodeficiency virus ( HIV ) result Positive genotyping test History cardiovascular , renal , hepatic , chronic respiratory gastrointestinal disease judge investigator Serious adverse reaction serious hypersensitivity drug formulation excipients Presence history clinically significant allergy require treatment , judge investigator . Hayfever allow unless active Where participation study would result donation blood blood product excess 500 mL within 56 day period Subjects taking , take , prescribed overthecounter drug ( hormone replacement therapy [ HRT ] /hormonal contraception contain ethinyl estradiol ) herbal remedy 14 day IMP administration Significant medical history fainting vasovagal attack History uncontrolled poorly control hypertension Semisupine systolic BP &lt; 90 mmHg &gt; 140 mmHg , diastolic BP &gt; 100 mmHg 3 assessment QTcB QTcF &gt; 450 msec male subject &gt; 470 msec female Presence history clinically significant abnormality vital sign ECG Presence medical condition , opinion investigator may interfere study procedure compromise subject safety Medical history clinically significant depression History suicide attempt within 6 month prior screen History acute porphyria History cardiac conduction disorder exception 1st degree heart block Mentally legally incapacitate Unwillingness inability follow procedure outline protocol , comply study restriction smoking , concomitant medication diet Failure satisfy investigator fitness participate reason</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>volunteer drug interaction study</keyword>
</DOC>